CA
NZ
UK
AU
IND
US
…
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Im Cannabis Corp is a publicly listed company that cultivates, processes and sells cannabis products and related services in regulated markets. Long-term growth may be driven by evolving regulatory frameworks, product diversification and potential expansion into additional markets which could support revenue scale. Investors may find exposure attractive for possible upside if the company can increase market share and improve operating margins within the regulated cannabis sector.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -11.66M | -12.79M | -9.46M | -26.06M | -18.01M |
| Minority interest | 0.43M | 1.19M | 2.01M | 2.41M | 0.76M |
| Net income | -11.32M | -10.59M | -9.50M | -24.92M | -18.52M |
| Selling general administrative | 11.64M | 11.30M | 16.28M | 24.10M | 39.69M |
| Selling and marketing expenses | 1.30M | 1.97M | 2.75M | 11.47M | 8.99M |
| Gross profit | 9.69M | 8.45M | 9.85M | 9.16M | 10.30M |
| Reconciled depreciation | 1.96M | 2.18M | 3.73M | 7.33M | 5.73M |
| Ebit | -8.90M | -8.33M | -5.79M | -26.41M | -38.39M |
| Ebitda | -6.95M | -6.14M | -2.79M | -12.37M | -10.64M |
| Depreciation and amortization | 1.96M | 2.18M | 3.00M | 14.03M | 27.75M |
| Operating income | -11.59M | -10.23M | -12.79M | -26.41M | -38.39M |
| Other operating expenses | 66.32M | 64.27M | 61.60M | 80.74M | 92.69M |
| Interest expense | 2.76M | 4.47M | 3.67M | 1.97M | 1.65M |
| Tax provision | 0.09M | -1.02M | -1.22M | -1.14M | 0.51M |
| Interest income | - | 1.91M | 5.75M | 6.70M | 22.02M |
| Net interest income | -3.17M | -2.56M | 3.78M | 4.73M | 20.38M |
| Income tax expense | 0.09M | -1.02M | 0.77M | -1.14M | 0.51M |
| Total revenue | 54.73M | 54.03M | 48.80M | 54.34M | 54.30M |
| Total operating expenses | 21.27M | 18.68M | 22.64M | 35.57M | 48.69M |
| Cost of revenue | 45.05M | 45.58M | 38.96M | 45.17M | 44.00M |
| Total other income expense net | -0.07M | -2.56M | 3.33M | 0.35M | 20.38M |
| Discontinued operations | - | - | - | -166.38M | -17.85M |
| Net income from continuing ops | -11.75M | -11.77M | -22.53M | -24.92M | -18.52M |
| Net income applicable to common shares | - | - | - | - | -17.76M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 31.74M | 39.19M | 48.81M | 60.68M | 287.39M |
| Intangible assets | 1.22M | 3.33M | 5.79M | 7.91M | 30.89M |
| Other current assets | 2.77M | 2.61M | 0.21M | 1.63M | 2.30M |
| Total liab | 35.35M | 36.04M | 35.11M | 36.88M | 82.44M |
| Total stockholder equity | -0.86M | 5.24M | 14.47M | 22.65M | 201.24M |
| Other current liab | 6.46M | 5.89M | 10.22M | 8.42M | 26.18M |
| Common stock | 270.52M | 265.00M | 253.88M | 245.78M | 237.68M |
| Capital stock | 270.52M | 265.00M | 253.88M | 245.78M | 237.68M |
| Retained earnings | -270.21M | -258.94M | -249.15M | -238.91M | -50.74M |
| Other liab | - | - | - | 1.59M | 13.00M |
| Good will | 1.89M | 6.68M | 10.11M | 9.77M | 121.30M |
| Other assets | - | - | - | 0.76M | 0.03M |
| Cash | 2.73M | 0.86M | 1.81M | 2.45M | 13.90M |
| Total current liabilities | 34.01M | 34.92M | 32.81M | 33.82M | 51.23M |
| Current deferred revenue | 0.21M | 0.49M | 0.79M | 0.03M | 0.14M |
| Net debt | 13.54M | 17.15M | 11.97M | 9.09M | 15.37M |
| Short term debt | 15.28M | 17.38M | 12.57M | 10.06M | 11.06M |
| Short long term debt | 14.96M | 17.11M | 12.12M | 9.25M | 9.50M |
| Short long term debt total | 16.27M | 18.01M | 13.78M | 11.53M | 29.27M |
| Other stockholder equity | 2.64M | 0.45M | - | 14.51M | 11.69M |
| Property plant equipment | - | - | - | 6.75M | 47.72M |
| Total current assets | 22.74M | 23.36M | 24.27M | 32.67M | 84.31M |
| Long term investments | 1.78M | 1.63M | 2.29M | 2.41M | 2.43M |
| Net tangible assets | - | - | - | 4.57M | 48.34M |
| Short term investments | - | - | - | - | 3.13M |
| Net receivables | 12.98M | 16.68M | 11.33M | 12.01M | 33.90M |
| Long term debt | 0.94M | 0.47M | 0.39M | 0.40M | 0.39M |
| Inventory | 4.27M | 3.21M | 10.91M | 16.59M | 31.08M |
| Accounts payable | 12.05M | 11.16M | 9.22M | 15.31M | 13.99M |
| Accumulated other comprehensive income | -3.81M | -1.26M | 9.73M | 1.28M | 2.61M |
| Non currrent assets other | - | - | 5.79M | - | 0.01M |
| Non current assets total | 8.99M | 15.82M | 24.55M | 28.00M | 203.08M |
| Capital lease obligations | 0.38M | 0.43M | 1.27M | 1.89M | 19.37M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.47M | -1.14M | -1.41M | -9.01M |
| Change to liabilities | - | - | - | 0.00M | 5.57M |
| Total cashflows from investing activities | -0.53M | -0.47M | - | -1.41M | -9.01M |
| Net borrowings | 1.18M | -1.55M | - | - | 7.17M |
| Total cash from financing activities | 1.15M | 3.83M | 11.08M | 4.76M | 48.73M |
| Change to operating activities | - | - | - | 16.25M | 9.95M |
| Net income | -11.75M | -11.77M | -9.50M | -191.30M | -18.52M |
| Change in cash | 1.86M | -0.95M | -0.64M | -11.45M | 5.02M |
| Begin period cash flow | 0.86M | 1.81M | 2.45M | 13.90M | 8.88M |
| End period cash flow | 2.73M | 0.86M | 1.81M | 2.45M | 13.90M |
| Total cash from operating activities | 4.72M | -1.08M | -9.74M | -12.64M | -34.37M |
| Issuance of capital stock | 5.07M | 0.94M | 2.27M | 3.76M | 28.13M |
| Depreciation | 1.96M | 2.18M | 3.00M | 7.33M | 5.73M |
| Other cashflows from investing activities | -0.52M | 0.03M | - | - | 0.02M |
| Dividends paid | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to inventory | -0.72M | 6.26M | 4.77M | 1.45M | -13.29M |
| Change to account receivables | 4.06M | -6.29M | 3.62M | 6.06M | -6.60M |
| Other cashflows from financing activities | -5.10M | 4.43M | 3.46M | 7.64M | 21.23M |
| Change to netincome | - | - | - | 134.44M | -11.55M |
| Capital expenditures | 0.01M | 0.16M | 0.58M | 1.56M | 4.59M |
| Change in working capital | 7.84M | 2.48M | 1.40M | 34.48M | -10.82M |
| Stock based compensation | 0.01M | 0.37M | 0.23M | 3.77M | 7.47M |
| Other non cash items | 6.82M | 5.81M | -5.26M | 136.09M | -18.51M |
| Free cash flow | 4.70M | -1.23M | -10.32M | -14.20M | -38.97M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| IMCC Im Cannabis Corp |
- -% |
0.64 | - | 42.37 | 0.02 | 0.95 | 0.30 | 4.60 |
| MKKGY Merck KGaA ADR |
-0.22 0.66% |
33.17 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
-2.76 1.62% |
167.12 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
-0.17 0.80% |
21.02 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
41.85 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Marc Lustig M.B.A., M.Sc. | Exec. Chairman | 1974 |
| Mr. Oren Shuster | CEO & Director | NA |
| Mr. Shai Shemesh | Chief Financial Officer | NA |
| Mr. Michael Ruscetta | Chief Exec. Officer of Trichome Financial Corp. | 1969 |
| Mr. Howard Steinberg C.F.A. | Chief Exec. Officer of TJAC & MYM | 1965 |
| Advocate Yael Harrosh | Chief Legal & Operations Officer | NA |
| Mr. Richard Balla | CEO & Director of German Operations ? Adjupharm GmbH | NA |
| Ms. Rinat Efrima | Chief Exec. Officer of Israel | 1977 |
| Mr. Marc Lustig M.B.A., M.Sc. | Executive Chairman | 1974 |
| Mr. Uri Birenberg | Chief Financial Officer | 1976 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...